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Abstract: The management of free-roaming horses (Equus ferus) and burros (E. asinus) in the

United States has been referred to as a “wicked problem” because, although there are population control options, societal values will ultimately determine what is acceptable and what is not.
In the United States, free-roaming equids are managed by different types of organizations and
agencies, and the landscapes that these animals inhabit vary widely in terms of access, size,
topography, climate, natural resources, flora, and fauna. This landscape diversity, coupled with
contemporary socioeconomic and political environments, means that adaptive management
practices are needed to regulate these free-roaming populations. The Bureau of Land Management (BLM) currently manages free-roaming equids on 177 herd management areas in the United States by applying fertility control measures in situ and/or removing horses, which are either
adopted by private individuals or sent to long-term holding facilities. The BLM off-range population currently includes >50,000 animals and costs approximately $50 million USD per year to
maintain; on-range equid numbers were estimated in March 2022 to be approximately 82,384.
On-range populations can grow at 15–20% annually, and current estimates far exceed the designated appropriate management level of 26,715. To reduce population recruitment, managers
need better information about effective, long-lasting or permanent fertility control measures.
Because mares breed only once a year, fertility control studies take years to complete. Some
contraceptive approaches have been studied for decades, and results from various trials can
collectively inform future research directions and actions. Employing 1 or more fertility control
tools in concert with removals offers the best potential for success. Active, iterative, cooperative, and thoughtful management practices can protect free-roaming horses while simultaneously protecting the habitat. Herein, we review contraceptive vaccines, intrauterine devices, and
surgical sterilization options for controlling fertility of free-roaming horses. This review provides
managers with a “fertility control toolbox” and guides future research.

Key words: castration, Equus asinus, Equus ferus, feral burros, feral horses, fertility control,
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Free-roaming horse (Equus ferus) and burro
(E. asinus) populations that inhabit designated
federal lands in the western United States are
protected by the Wild Free-Roaming Horses
and Burros Act of 1971 (Public Law 92-195). This
legislation requires the Bureau of Land Management (BLM) and the U.S. Forest Service (USFS)
to manage populations to achieve and maintain

a thriving, natural ecological balance. The USFS
oversees 34 Wild Horse and Burro Territories,
while the BLM manages wild horses and burros on 177 Herd Management Areas (HMAs)
across 10 western states. In an attempt to define an ecological balance, the BLM determined
the Appropriate Management Level (AML) for
each HMA (National Research Council [NRC]
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Figure 1. Different geographic landscapes supporting free-roaming horse (Equus ferus)
populations in the United States. (A) The Pryor Mountains Herd Management Area (HMA)
in southern Montana, USA, straddles the Crow Indian Reservation, Custer National Forest,
and private land, covered in shrub-grass vegetation, Douglas fir (Pseudotsuga menziesii),
lodgepole (Pinus contorta) and limber (Pinus flexilis) pine, and juniper (Juniperus spp.);
temperatures range from -14–31°C. (B) The King Top Mountains HMA in west-central Utah,
USA, has pinyon (Pinus edulis) and juniper communities on upper slopes and sagebrush
(Artemisia nova), shadscale (Atriplex confertifolia), and ricegrass (Oryzopsis hymenoides)
at lower elevations. (C) The Challis HMA in central Idaho, USA, ranges in elevation from
1,400 to nearly 2,450 m; high ridges have Douglas fir, sagebrush occupies wide basins, and
riparian areas contain willows (Salix wolfii), birch (Betula papyrifera), and aspen (Populus
tremuloides); temperatures range from -9–21°C. (D) The Sand Wash Basin HMA in northwestern Colorado, USA, includes public, private, and state land, covered in sagebrush and
bunchgrass (Festuca viridula), saltbush (Atriplex confertifolia) and pinon-juniper woodlands;
temperatures range from -3–38°C. (E) The Pine Nut Mountains HMA in west-central Nevada, USA, just east of Carson City, includes private and public lands with peak elevations of
2,700 m; vegetation consists of pinyon pine, juniper, sagebrush, and grasses; temperatures
range from -12–38°C. (F) Chincoteague Island, northeastern Virginia, USA, just south of
Assateague Island National Seashore, Maryland, USA, vegetation ranges from salt-tolerant
plants (e.g., Cakile edentula) and grasses (e.g., Ammophila breviligulata) in dunes and salt
marshes to loblolly pines (Pinus taeda) and shrubs (e.g., Rubus argutus) surrounding freshwater wetlands; temperatures range from 17–38°C (photos courtesy of J. Turner [A and C],
D. Stoner [B and E], K. Grams [D], and U. Bechert [F]).
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2013). The current AML of HMAs has been set
at 26,785 (BLM 2022); however, in March 2019,
>80% of the HMAs exceeded their AML (BLM
2020). Garrott (2018) reported that given annual
growth rates of 15–20%, populations are currently overwhelming management actions.
Because HMAs vary in size (from ~800 to
>526,800 ha), topography, climate (Stoner et al.
2021), natural resources, and flora and fauna,
they create different challenges for population
management (Figure 1). Free-roaming burros
may have positive effects on the landscape (e.g.,
shrub clearance, seed dispersal) as reported in
29% (10 of 34) of studies that examined environmental effects (Clancy et al. 2021). Lundgren et al. (2021) also reported free-roaming
equids can expand water resources for other
species by digging <2-m-deep wells in deserts.
However, most studies report that overabundant equids can compact soils, increase erosion,
and decrease plant cover (Ostermann-Kelm et
al. 2009), compete with native fauna over resources, and be associated with loss of biodiversity (Davies and Boyd 2019, Coates et al.
2021). Native species like mule deer (Odocoileus
hemionus) occur on 97% of BLM and USFS managed lands, and pronghorn (Antilocapra americana) are found on 82% (Stoner et al. 2021).
Climate change is altering habitats and ecosystem processes on some rangelands (McCollum
et al. 2017) and will necessitate a review of AMLs.
Factors such as drought or fire can have a more
pronounced effect on vegetation and forage availability than locally overabundant free-roaming
equid populations (Briske et al. 2005, Vetter 2005,
Briske et al. 2015). Invasive species, like cheatgrass (Bromus tectorum), also affect rangelands
and could be spread by horses (King et al. 2019).
However, management goals should aim to preserve ecological processes rather than specific
species (Perryman et al. 2021).
Free-roaming equids inhabit landscapes that
are managed by different types of organizations and agencies in addition to the BLM and
USFS, including First Nations, state and county
governments, military organizations, the National Park Service (NPS), state and federal fish
and wildlife agencies, private landowners, and
other groups (Beever et al. 2018). Schoenecker
et al. (2021) estimate that almost 300,000 feral
equids now inhabit U.S. landscapes. Managing populations of free-roaming equids is thus
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a significant challenge, involving animal welfare, environmental, sociological, public policy,
and economic dimensions (Scasta et al. 2018).
Because of changing socioeconomic and political variables as well as dynamic ecosystems,
adaptive management of free-roaming equid
populations is required. This is an iterative
decision-making process that relies on consistent quantitative and qualitative monitoring,
reliable models to develop predictions of future
changes, and reviewing and adjusting management actions (Holling 1978, Briske et al. 2008).
Horses and burros, while both equids, have
different survival and reproductive strategies.
Burros are better adapted to hot, dry conditions and low-quality forage than are horses
(Seegmiller and Ohmart 1981, Izraely et al. 1989,
Burden and Thiemann 2015), and they can travel
long distances (Gedir et al. 2021). Unlike the harem structure of horses, burros living in arid environments, like the southwestern United States,
have a fission-fusion social system with no permanent bonds between adult individuals; however, in mesic environments, they can also form
stable harem groups (Moehlman 1998).
Burro numbers were estimated to total 17,780
on BLM lands in March 2022, with the largest
populations in Arizona, USA, followed by Nevada and California, USA (BLM 2022). Burros
can become reproductively active as early as
10–12 months of age (Perryman and Muchlinski 1987); they are polyestrous and can mate
throughout the year, although some populations have a peak breeding season in the late
spring and summer (Grinder et al. 2006).
In a given population, up to 72% of the jennies may be pregnant (Wolfe et al. 1989), and
poor physical condition does not appear to
have a significant effect on fecundity (Perryman and Muchlinski 1987, Choquenot 1991).
In 1 population, 60% of the lactating females
were also pregnant, and males tended to live
longer than females (Johnson et al. 1987). Burro
populations can skew young with few animals
living >10 years of age (Johnson et al. 1987). Immunocontraception requiring multiple doses of
porcine zona pellucida (PZP) effectively contracepted small populations of jennies on geographically closed islands (Turner et al. 1996,
French et al. 2020); however, open free-ranging
populations could not be successfully managed this way (Gedir et al. 2021). Few studies
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focused on fertility control of burros have been
conducted (Clancy et al. 2021); however, it is
possible that contraceptive options for horses
could be adapted for burros in the future with
consideration for how social system differences
may affect male harassment of jennies in estrus.
In contrast, free-roaming horses consume primarily grasses (King and Schoenecker 2019),
with forbs and shrubs comprising <8% of the
diet (Hubbard and Hansen 1976). Horses usually belong to social groups or harems that occupy home ranges (McCort 1984). Mares become
reproductively active up to 6 months later than
jennies, and they are seasonal long-day breeders,
mating only during the summer. The gestation
period for the mare is 37–38 days shorter than
the jenny (Fielding 1988), free-roaming mares
usually live longer (up to 15 years or more), and
the foal survival rate is comparatively greater
(Johnson et al. 1987, Garrott et al. 1991).
The BLM currently manages free-roaming
horse populations by applying fertility control
measures in situ and removing animals from
the range. The BLM estimated the on-range
horse population to be approximately 79,568
in March 2020 (BLM 2021) and 64,604 in March
2022 (BLM 2022), which is still significantly over
AML. Horses removed from the range are either
adopted by private individuals or sent to longterm holding facilities. Younger horses may be
adopted by members of the public, but about
half of the 84,741 horses removed between 2000
and 2009 ended up in long-term holding (Vincent 2010). Although the overall adoption rate
has increased over the past 4 years (BLM 2020),
the growing supply greatly exceeds the demand
(Hendrickson 2018). The off-range population
includes >45,000 horses and costs approximately
$50 million USD per year to maintain (Garrott
2018), and in 2019, off-range holding costs consumed 67% of the BLM Wild Horse and Burro
Program’s budget (BLM 2019).
A suite of effective, long-lasting, or permanent
fertility control solutions is needed to manage
free-roaming horse populations. Research on a
specific fertility control option typically starts
with 1 or more laboratory-based or clinical studies to develop proof of concept before moving
to field trials. However, not uncommonly, additional research with captive animals is needed to
address challenges experienced during field trials, learn more about the mechanism(s) of action,

Human–Wildlife Interactions 16(2)
and/or fine-tune treatment strategies. Horses are
seasonal long-day breeders that foal once a year,
so trials to determine contraceptive efficacy (especially long-term efficacy) take years to complete. The choice of particular fertility control
method(s) in each HMA will depend on management goals, the region’s particular geographic, socioeconomic, and biological characteristics,
as well as the demographic characteristics and
approachability of the horses.
Our review will focus on horses because more
fertility control research has been conducted
with horses, they are physiologically different
from burros (Burden and Thiemann 2015), and
burro populations are comparatively smaller in
size (Schoenecker et al. 2021). This review summarizes what is known about several horse contraceptive and sterilization options, as well as
considerations for implementation, to provide
managers with a “fertility control toolbox” and
guide future research and management efforts.

Methods

The Free Roaming Equids and Ecosystems
Sustainability Network (FREES; https://extension.usu.edu/freesnetwork/) Population Management Working Group developed a list of fertility control options that have been researched
in horses, are currently available, or are in development. Members of the working group also
gave presentations as part of a panel at the 2020
FREES Summit “Connecting the Dots” in Cody,
Wyoming, USA, which included an overview
of fertility control options, constraints of implementing fertility control and removals, and
population modeling.
In this paper, we provide an in-depth review
of horse fertility control options that the BLM
has considered, including: immunocontraceptive vaccines, intrauterine devices (IUDs), and
surgical options, with contributions from authors who have conducted research in these
areas. Details of each fertility control option are
reviewed based on previously published results, current projects are briefly described, and
remaining questions and future research needs
are identified. Considerations for implementation, which vary from 1 geographic location to
another and include regulatory requirements,
are also described.
Currently available tools (i.e., officially approved for use) as well as promising new fertil-

Figure 2.
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Figure 2. The reproductive system of the mare (Equus ferus) depicting (A) endocrine relationships
(adapted from Hiller-Sturmhöfel and Bartke 1998) and immunocontraceptive targets; (B) side view
of reproductive organs (adapted from Momont 2019) with ovariectomy incision and écraseur placement sites.

ity control options are included to help horse
population managers develop a greater level of
understanding and assess ability to implement
1 or more alternatives under different scenarios
and management goals. Except for castration,
all options focus on fertility control of mares
because a single male can inseminate numer-

ous females (Garrott and Siniff 1992). The use
of contraception as a means of free-roaming
horse fertility control was introduced in the
1970s with the successful field use of steroid
hormones in males (Turner and Kirkpatrick
1982) and females (Eagle et al. 1992, Plotka et
al. 1992). However, hormonal fertility control
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options (e.g., estradiol-17β or progesterone implants) are not included in this review because
these hormones could potentially enter the
food chain and they are not considered to be an
option by the BLM (Kane 2018).

Results and discussion

Immunocontraception

Contraceptive vaccines work by stimulating
the immune system to produce antibodies that
bind to specific molecules, usually proteins,
affiliated with the reproductive system and
impede fertility (Figure 2A). Vaccines are constructed by combining 3 primary components:
(1) the antigen, (2) 1 or more adjuvants, and (3)
the formulation or diluent that make up the
final product and the way it is delivered. The
antigen determines how the vaccine works.
Importantly, the key to immunocontraception,
which differs from traditional immunizations,
is that the class of antigen is endogenous to
the animal; thus, making the immune system
responsive is often difficult. For example, PZP
vaccines stimulate the immune system to produce antibodies to the zona pellucida (ZP),
which surrounds the oocyte and facilitates
sperm binding. When PZP antibodies occupy
the mare’s zona pellucida receptors, sperm are
unable to bind to the oocyte, and fertilization
cannot take place. The adjuvant, the second
part of the immunocontraceptive, increases
the immune response to an antigen in various
ways (Awate et al. 2013, Brito et al. 2013). For
example, Modified Freund’s Adjuvant (MFA) is
an oil-based adjuvant made with freeze-dried
fractionated cell walls of Mycobacterium butyricum that stimulates immune cells to produce
antibodies against the antigen component of
the vaccine (Lyda et al. 2005). The formulation
may also include 1 or more different classes
of immune potentiators (Brito et al. 2013), including agonists of innate activation systems
like Toll-like receptors (e.g., Poly(I:C) used in
recombinant PZP vaccines; Nolan et al. 2018).
Contraceptive vaccines can target gamete
(sperm or egg) production (e.g., gonadotropin
releasing hormone; GnRH), gamete maturation
(e.g., oocyte growth factors), gamete function
(e.g., PZP), or gamete outcome (e.g., maternal recognition factors; Naz et al. 2005, Kaur
and Prabha 2014). Other antigens, in addition
to PZP, may target gamete function, but they

have not yet been tested in horse contraceptive
vaccines. For example, a sperm surface protein
(Izumo) facilitates binding to the egg receptor
(Juno) and prevents polyspermy (Bianchi et
al. 2014, Ohto et al. 2016). Vaccination against
Izumo reduced fertility in female mice (Mus
musculus) by inhibiting sperm penetration, and
infertile women often have antibodies to Izumo
(Naz 2014). Research has focused on other aspects of fertility including maternal recognition
of pregnancy. Maternal recognition of pregnancy prevents lysis of the corpus luteum to maintain progesterone production and pregnancy;
however, different agents serve as maternal recognition factors (MRF) in different species (Bazer 2015, Raheem 2017). For example, the MRF
is human chorionic gonadotropin in humans,
estrogen in pigs (Sus domesticus), interferon
tau in ruminants, but it is not known what the
agent is in mares (Raheem 2017). Equine chorionic gonadotropin plays a key role in the development of accessory corpora lutea in mares,
but only after day 40 of pregnancy (Klein 2016).
In this section, we review 5 immunocontraceptive vaccines that vary by antigen, adjuvant,
and formulation, as well as treatment protocols.
Each vaccine’s characteristics will make it more
or less suitable to a particular scenario based on
implementation constraints, contraceptive efficacy, safety, and management goals.
Porcine zona pellucida (PZP). Three different
kinds of PZP-based vaccines (i.e., ZonaStat,
PZP-22, and SpayVac®) have been used in
horses, as well as experimental recombinant
versions (Joonè et al. 2017a, Nolan et al. 2018).
The ZP is comprised of 3 or 4 different glycoproteins. The mouse ZP has 3 glycoproteins
(ZP1, ZP2, and ZP3); however, most mammalian species also have ZP4, including other
rodents (Izquierdo-Rico et al. 2009), ungulates
(Topper et al. 1997), rabbits (Oryctolagus cuniculus; Stetson et al. 2012), and humans (Lefievre et
al. 2004). The glycoprotein ZP3 acts as the primary sperm receptor in mice; however, in humans and other species, ZP3 as well as ZP1 and
ZP4 bind to sperm and induce the acrosome
reaction, which allows for penetration of the
ZP by sperm (Gupta et al. 2012). The primary
ZP glycoproteins in the PZP-based vaccines described below include ZP2, ZP3, and ZP4 (D.
Kroeger, SpayVac-for-Wildlife, Inc., personal
communication). The PZP vaccines specifically
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Figure 3. Vaccine delivery methods in horses (Equus ferus) include (A) remote darting targeting the hamstring muscles, and (B) hand-injections in either neck or gluteal muscles. The 2 major lymph nodes differ in
distance to injection sites (photos courtesy of M. Thompson [A] and U. Bechert [B]).

target reproductive tissues, so they are safe to
use (e.g., can be administered during pregnancy and lactation) and do not persist in the environment (Hobbs and Hinds 2018).
In 1985, based on successful fertility reduction (86%) using native PZP vaccine in 14 domestic mares (Liu et al. 1989), the team of Kirkpatrick, Turner, and Liu began a multi-study
program testing PZP vaccine in free-roaming
horses. Early in the research program, a list of
“ideal” characteristics desired for a contraceptive vaccine was developed. It included: safety,

efficacy, reversibility, no passage through the
food chain, continued basic social/sexual behavior, pregnancy and offspring unaffected,
deliverable remotely, and cost effective (Kirkpatrick and Turner 1985).
The PZP antigens in ZonaStat-H (Science
and Conservation Center, Billings, Montana,
USA) are obtained by mincing pig ovaries (obtained from local abattoirs) using a ganged
razorblades apparatus. Oocytes are counted
and filtered to obtain the zonae pellucida in
phosphate buffered saline (PBS). The solution
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is then homogenized, solubilized at 70°C for
40–60 minutes, and stored frozen at -20°C. The
vaccine is an emulsion of 100 µg aqueous PZP
(0.5 mL) in PBS plus 0.5 mL MFA to create the
primer dose, and the booster uses Freund’s incomplete adjuvant, which lacks the mycobacterial component. When properly emulsified, the
vaccine can be kept on ice for 24 hours prior to
administration.
The first field trial of ZonaStat-H in freeroaming horses began in 1988 on Assateague Island (ASIS) National Seashore, Maryland, USA.
Treatment consisted of an initial vaccination
(primer) followed by a booster 3–4 weeks later
all delivered via remote darting (similar to that
depicted in Figure 3A). None of the 26 treated
mares foaled the following year, compared to a
49% foaling rate for untreated mares (Kirkpatrick and Turner 1990). From 1989 to 1994, >50%
(and up to 70%) of the ASIS mares received
primer plus booster or annual booster treatments and averaged only a 3.5% fertility rate
(Turner and Kirkpatrick 1991, Kirkpatrick 1995).
A remote (fecal) early pregnancy determination
method was also developed there (Kirkpatrick et
al. 1991). In 1994, the (NPS) adopted ZonaStatH as the sole population management tool for
ASIS horses, achieving zero population growth
by 2001 (Ballou et al. 2008). The NPS achieved a
32% decrease in population size by 2011 and has
maintained their ZonaStat-H management goal
since 2016 (NPS 2020; Figure 4). No ASIS horse
has been removed for population control.
Importantly, the ASIS study established a
clear profile of safety for PZP vaccines, showing reversibility and no effect on existing pregnancies (Kirkpatrick et al. 1992; Kirkpatrick
and Turner 2002, 2003). Contraception was also
associated with improved body condition and
extended longevity (Kirkpatrick and Turner
2007, 2008). Behaviorally, basic social and sexual patterns were found to be similar among
treated and untreated mares in other populations examined (Powell 1999). However, some
studies have shown that PZP treatment can affect behavior after the usual breeding season,
including reduced mare band fidelity and extension of estrous cycling with impacts on stallion behavior (Madosky et al. 2010, Ransom et
al. 2010, Nuñez et al. 2017). Possible long-term
consequences of such behavioral alterations or
adaptation to them are not reported.
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The use of ZonaStat-H in western free-roaming horses and elsewhere began in the early
1990s (Turner et al. 1996, 1997) with involvement of the BLM. Since 2005, >10,000 mares
have been treated with ZonaStat-H (primarily
by darting) in herds on BLM, NPS, USFS, state,
sanctuary, and First Nations lands (K. Frank,
Science and Conservation Center, and B. Wade,
BLM Wild Horse and Burro Program, personal communications). In some smaller herds,
in which 50–80% of mares have been treated
annually, horse removals have been sharply
reduced, and in some cases, zero population
growth has been achieved (Kirkpatrick and
Turner 2008, NPS 2020; K. Frank, Science and
Conservation Center, personal communication). ZonaStat-H is registered by the U.S. Environmental Protection Agency (EPA, registration #86833-1) and is produced by the Science
and Conservation Center in Billings, Montana.
Because the ASIS vaccination protocol of 2
initial injections with annual boosters is labor
intensive and unsuitable for use on wary and
widely dispersed herds common on western
public lands, it was crucial to develop a singleinjection PZP vaccine with multi-year effectiveness. Beginning in 1990, the BLM funded a series
of studies testing PZP treatments that added
PZP packaged in controlled-release lactide/glycolide polymers to the ZonaStat-H vaccine.
Large-scale field tests employing vaccine
with controlled-release polymer microspheres
were conducted on mares gathered by helicopter (as part of removal management actions) at
the Antelope HMA (n = 127) in northeastern
Nevada in 1992 and the Nevada Wild Horse
Range in central Nevada (NWHR; n = 222) in
1996. In both studies, foaling rates of mares receiving a single injection of ZonaStat-H plus
microsphere-encapsulated PZP were compared
to mares receiving the 2-injection ASIS protocol.
In the Antelope HMA study, the microsphere
treatment reduced fertility by 73% but was less
effective than the 2-injection protocol (Turner et
al. 1997). However, addition of adjuvant (Carbopol 934) in microspheres at the NWHR study
yielded contraceptive efficacy that matched the
2-injection protocol, with both preparations
exceeding 80% fertility reductions over a year
(Turner et al. 2000).
From 1996 to 2000, controlled-release preparations were modified and improved in the lab,

Figure 4.
9

Free-roaming horse fertility control options • Bechert et al.

Foals

200

March population

180

Number of horses

160
140
120
100

population

60
40
20

Year (1969-2013)
Figure 4. Effect of long-term ZonaStat-H vaccine treatment (primer + 1-month booster and subsequent
annual boosters) delivered by dart to >50% of mares in the free-roaming horse (Equus ferus) population
inhabiting Assateague Island National Seashore, Maryland, USA, from 1989 to 2013. Personnel performed
horse census counts by individual identification annually in March starting in 1975.

and then tested in captive mares and in the
field (Turner et al. 2002, 2007). Studies of PZP
antibody titers across 2 years in captive mares
yielded a preparation (eventually named PZP22; Science and Conservation Center, Billings,
Montana) that maintained contraceptive-level
titers for 22 months post-immunization (Liu et
al. 2005). PZP-22 consists of a single injection
containing the ZonaStat-H primer dose plus 3
different polymer mini-pellets matrixed with
PZP and a saponin adjuvant (QA-21) to mimic
the initial and first annual ZonaStat-H boosters
(Turner et al. 2008).
Offering the prospect of a single injection,
2-year PZP vaccine, PZP-22 was used in its first
field trial on 100 mares gathered, treated, and
released at Clan Alpine HMA, Nevada, beginning in 2000. In the 3 years following PZP-22
treatment, fertility was reduced by 89%, 74%,
and 41% relative to untreated mares, returning
to full fertility in the fourth year (Turner et al.
2007). This study demonstrated PZP-22 multiyear efficacy and reversibility.
With the support of the Annenberg Foundation, the Humane Society of the United States,

and the BLM, 3 subsequent field trials of PZP22 were carried out between 2008 and 2014 at
Cedar Mountain HMA, Utah, Sand Wash Basin
HMA, Colorado, and Jarita Mesa Wild Horse
Territory, New Mexico, USA. While designed
to examine population-level and longer-term
behavioral effects, these studies also provided
data about the impacts of seasonal timing and
method of PZP-22 delivery on contraceptive
efficacy. Mares in New Mexico were treated
with PZP-22 via remote dart and had significantly lower foaling rates the following year
(Carey et al. 2019). Cedar Mountain and Sand
Wash Basin mares had the highest rates of contraceptive efficacy when hand-injected PZP-22
was administered in February, moderate rates
in December, and the lowest rates of effectiveness when administered in October (Rutberg et
al. 2017), demonstrating the importance of season in timing treatments. For mares at Cedar
Mountain and Sand Wash Basin that were given a ZonaStat-H or PZP-22 booster 2–3 years after initial vaccination with PZP-22 (n = 107): (1)
mares experienced reduced fertility by 66–78%
over 3–4 years (P < 0.01 for all years); (2) booster
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treatments were effective when delivered by
hand-injection or remote dart; and (3) 2 cycles
of gathers and treatments sharply reduced
population growth (Rutberg et al. 2017). Because these 3 studies required regular observations (e.g., physical condition, basic behaviors)
of >200 individual horses during April through
October for 4–7 years, strong confirmation of
PZP-22 field use viability was established.
Accumulated field reports of injection site
reactions to ZonaStat-H and PZP-22 vaccines
were <25% across studies, with reactions primarily mild and disappearing without consequence in several weeks (K. Grams, Science
and Conservation Center, personal communication); an observational study of 306 injection site reactions in 85 mares found that none
were debilitating (Roelle and Ransom 2009).
From a safety viewpoint, PZP-22 differs from
EPA-registered ZonaStat-H only in the addition of controlled-release pellet components,
which have already been approved by the U.S.
Food and Drug Administration for other uses
(e.g., grafts, sutures, implants, food). Across the
years of use, both ZonaStat-H and PZP-22 injections were delivered in the upper rump.
The PZP-22 costs more per treatment than
ZonaStat-H but requires less frequent administration, which offsets the cost difference
across years, especially when access to horses
is challenging. Recent models using published
data (Turner et al. 2007, Rutberg et al. 2017) for
PZP-22 with a ZonaStat-H booster in a 50%
treatment and 50% removal pattern across 10
years yielded a 39% lower cost than removals
alone (J. Turner, University of Toledo, unpublished data). Technical improvements on PZP22 to further reduce costs, increase efficacy,
eliminate injection site reactions, and simplify
handling are in progress. These include innovations like no-mix primers, increased precision
in the timing of vaccine release from pellets,
novel adjuvants, and using recombinant-ZP as
a substitute for PZP in ZonaStat-H. As a reversible contraceptive, PZP-22 can be integrated
with limited removals and other tools, enabling
free-roaming horses to have quality lives and
a role in determining their own genetic future.
SpayVac. This contraceptive vaccine was developed in the early 1990s to control grey seal
(Halichoerus grypus) populations along the Atlantic coast of Canada (Bechert and Fraker 2018).
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Liposomes were used to encapsulate PZP antigens in an effort to provide sustained release
over an extended period of time. Liposomes
are multi-lamellar, concentric spheres made up
of phospholipid bilayers separated by aqueous
compartments and may themselves be considered immunological adjuvants (Allison and Gregoriadis 1974, Shek and Sabiston 1982). Fertility
rates for 101 female seals treated with a single
injection of SpayVac dropped from 70–75% to
9–15% for years 2–5 (Brown et al. 1997a) and 10
years post-vaccination (Fraker and Brown 2011).
These remarkable results served as the foundation to launch IMV, Inc. (Halifax, Nova Scotia,
Canada), a biopharmaceutical company that
now develops human cancer immunotherapies and infectious disease vaccines using this
patented liposome technology (IMV, Inc. 2021).
SpayVac-for-Wildlife, Inc. (Sidney, British Columbia, Canada) has an exclusive, global license
from IMV to use this technology in contraceptive
vaccines for native wildlife and feral mammals.
The PZP in SpayVac (SpayVac-for-Wildlife,
Inc.) is isolated by grinding trimmed ovaries
and then passing the ground tissue through a
series of nylon screens as described by Brown et
al. (1997b). Either 200 or 400 µg PZP doses have
been used in SpayVac horse vaccines. Two types
of adjuvants have been used in SpayVac formulations: MFA or AdjuVac, which uses Mycobacterium avium in mineral oil (National Wildlife
Research Center [NWRC], Fort Collins, Colorado). Both MFA and AdjuVac produce less severe
inflammatory responses compared to Freund’s
Complete Adjuvant (Lyda et al. 2005, Powers
et al. 2007). IMV, Inc. has developed 2 patented
liposome-based formulations: (1) VacciMax, a
water-in-oil emulsion (MacDonald et al. 2010),
and (2) a freeze-dried version (https://www.
imv-inc.com/the-dpx-platform), which undergoes a lyophilization step with the components
resuspended in oil just prior to injection (Brewer
et al. 2018). VacciMax formulations need to remain frozen until shortly prior to use, whereas
freeze-dried vaccines can be stored under less
stringent conditions and reconstituted when
needed, making them easier to use in the field.
Most SpayVac field trials in wildlife have used
the original VacciMax formulation.
Three SpayVac trials in horses have been conducted. The first trial used SpayVac VacciMax
formulated with 400 µg PZP and AdjuVac in-
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jected intramuscularly (IM) in the neck (Killian
et al. 2008). Pregnancy rates dropped to 0, 17,
17, and 17%, respectively, 1–4 years after treatment of mares with a single SpayVac injection
(n = 12), compared to 75, 75, 88, and 100% for
untreated mares (n = 8).
The second study used 200 µg PZP with MFA
and both types of liposome formulations in 2
treatment groups (Bechert et al. 2013). Three to
4 months post-vaccination IM in the neck with
SpayVac VacciMax (n = 7) or the freeze-dried
version (n = 7), 93% of treated mares ceased cycling as evidenced by lower serum concentrations of progesterone (P < 0.025) and smaller
ovaries with fewer follicles (P < 0.001) compared
to controls (n = 7), while other organ systems
were unaffected. The direct effects of vaccination on the ovaries of treated horses may represent a second contraceptive mechanism of action
for PZP, in addition to interference with sperm
binding. A subsequent study in ponies (Joonè et
al. 2017a), using a similar experimental design
and different PZP vaccines administered in the
gluteal muscles (100 µg PZP in MFA followed by
a booster with another 100 µg PZP in Freund’s
Incomplete Adjuvant), also found suppression
of ovarian function in 86% of treated mares (n =
7). Earlier endocrine data based on longitudinal
fecal samples collected from mares treated with
ZonaStat-H on Assateague Island had suggested
that ovulatory failure occurred frequently (Kirkpatrick et al. 1995, Powell and Monfort 2001). A
variety of mechanisms of action for ovulatory
failure has been suggested, including contamination of the antigen with non-ZP ovarian proteins and effects of cytotoxic T-cells (Bechert et
al. 2013, Joonè et al. 2017b).
The third SpayVac trial in horses also used
200 µg PZP with MFA and both types of liposome formulations in 2 treatment groups; however, single injections were administered into
gluteal muscles instead of the neck (Roelle et
al. 2017). Fertility for the VacciMax group (n =
30) was lower (P < 0.001) at 13, 47, and 43% for
years 1–3 post-vaccination, compared to 100,
98, and 100% of controls (n = 30). Although fertility in mares treated with the freeze-dried formulation (n = 30) was 17% in the first year, this
increased to 76% in year 2, and this group was
removed from the study. The immune response
and contraceptive efficacy clearly differed from
the first 2 SpayVac studies in horses.
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In an effort to understand the difference, frozen serum samples from the VacciMax treated
group in the Roelle et al. (2017) study were used
to determine potential differences in specific
immunoglobulin G (IgG) isotype responses
(Bechert et al. 2018). The predominant antibody
class in equine serum and the major component
of humoral immunity is IgG, and horses have
7 different IgG isotypes (Wagner et al. 2004).
Previous studies have demonstrated a positive
correlation between levels of PZP antibodies
produced and contraceptive effect (Liu et al.
1989); however, individual mares that were
consistently infertile did not necessarily have
the highest antibody titers (Roelle et al. 2017).
Instead of using ELISA (enzyme-linked immunosorbent assay) to determine PZP antibody
titers, a more sensitive fluorescent bead-based
assay was used to distinguish IgG isotype responses against PZP. Serum samples collected
1, 2, and 4 years post-vaccination from mares
that were continuously infertile (n = 14) were
compared with samples from those that had
foaled at least once during the 4-year period (n
= 14). Samples from the continuously infertile
mares were also collected and analyzed 5 years
post-vaccination. While IgG1 antibodies were
generally higher in infertile compared to fertile
mares, only IgG4/7 antibody levels were significantly higher in infertile mares during years 1
and 2 post-vaccination (P < 0.05; Bechert et al.
2018). Surprisingly, IgG4/7 isotype levels were
significantly higher during year 5 compared
to year 4 in the continuously infertile mares
(P < 0.02). SpayVac’s ability to preferentially
stimulate IgG4/7 antibodies may contribute to
its long-term immunocontraceptive efficacy,
and measuring IgG4/7 isotypes may help differentiate effectively contracepted mares from
those that may need additional vaccination.
However, an understanding of why some of
these mares mounted a more robust immune
response compared to others was still lacking.
Horses are typically given IM injections in
either the neck or the rump, which are generally viewed as equivalent. However, in other
species, injection site is known to influence vaccine efficacy. For example, hepatitis B vaccinations are successful when given into deltoid,
but not gluteal, muscles in humans (Caldwell
et al. 1985), and the reason is proximity to regional lymph nodes (Eggert et al. 1999, Mould
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et al. 2017). Horses have 2 pairs of primary
lymph nodes: the superficial cervical lymph
nodes, located very close to the neck injection
site, and the sub-iliac lymph nodes, which are
located further from hindquarter injection sites
(Gaedke et al. 2013, Blenntoft 2020; Figure 3B).
Dendritic cells are located in tissues like the
skin where their receptors trap antigens; then
they migrate to lymph nodes where they interact with T and B cells to stimulate an immune
response (Eggert et al. 1999, Randolph et al.
2005). After successful antigen stimulation or
vaccination, long-lived plasma cells produce
large amounts of high-affinity IgG antibodies.
Vaccine efficacy can be improved by enhancing dendritic cell maturation and migration to
the lymph nodes (Mould et al. 2017) and considering IgG isotypes in vaccine development
(Goodman et al. 2012). We suspect that the
closer proximity of the neck injection site to the
superficial cervical lymph node facilitates dendritic cell uptake of PZP antigens, resulting in
a more robust immune response compared to
rump injection sites, which are further from the
sub-iliac lymph nodes.
Future and ongoing research with SpayVac
for horses include studies to: (1) confirm how
injection site may affect immune response and
contraceptive efficacy, (2) explore a potential
increase in contraceptive efficacy when a booster dose is administered several years after the
initial SpayVac injection, (3) develop a freezedried formulation that would make SpayVac
even easier to administer in the field, and (4)
test SpayVac in burros. An EPA application to
register SpayVac-Equid, formulated with 400
µg PZP and MFA, is expected to be submitted
within the next year.
Gonadotropin releasing hormone (GnRH). GonaCon-Equine is registered by the EPA for application in adult female horses and burros (NWRC,
Fort Collins, Colorado). It takes advantage of the
role played by GnRH in regulating mammalian
reproduction (Figure 1A). The GnRH stimulates
release of gonadotropins (i.e., follicle stimulating hormone and luteinizing hormone) from the
anterior pituitary gland, which in turn regulate
both endocrine function and gamete maturation
in the ovaries and testes (Garza et al. 1986). The
GnRH is a small neuropeptide that is a weak antigen, but when conjugated to a highly immunogenic carrier protein (Blue Carrier; Biosonda,
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Santiago, Chile) and combined with AdjuVac,
vaccination stimulates an immune response resulting in antibody production against endogenous GnRH. These antibodies subsequently
induce transient infertility by binding to GnRH,
thus preventing attachment to receptors on pituitary gonadotrophs, inhibiting gonadotropin release, and ultimately suppressing follicular development, estrus, and ovulation in females (Hazum and Conn 1988). As anti-GnRH antibodies
decline over time, the availability of endogenous
GnRH increases, and treated animals generally
regain normal fertility (Gionfriddo et al. 2011b,
Powers et al. 2014, Baker et al. 2018).
A single immunization with GonaCon induced infertility for up to 2+ years in numerous wild ungulate species, including captive
and free-ranging white-tailed deer (Odocoileus
virginianus; Miller et al. 2008, Gionfriddo et al.
2011a), bison (Bison bison; Miller et al. 2004), elk
(Cervus elaphus; Killian et al. 2009; Powers et al.
2011, 2012, 2014), feral cattle (Bos taurus; Massei
et al. 2015, 2018), and horses (Killian et al. 2008,
Gray et al. 2010, Baker et al. 2018). Multiple
years of infertility, however, are experienced in
only a fraction of vaccinated animals, and this
limitation has been shown to be particularly
true for free-roaming horses (Killian et al. 2008,
Gray et al. 2010, Baker et al. 2018).
Adverse side effects following a single or
booster immunization appear to be minimal in
a majority of wild ungulates studied, including
white-tailed deer (Curtis et al. 2008, Gionfriddo
et al. 2011b), elk (Powers et al. 2011, 2012, 2014),
bison (Miller et al. 2004), and free-roaming
horses (Baker et al. 2018). GonaCon-Equine has
been demonstrated to be safe for pregnant females and neonates and does not result in adverse behavioral side effects (Baker et al. 2018).
Several studies have shown that vaccinated
and control mares display no differences in
frequency or intensity of social behaviors that
maintain herd structure (e.g., herding, tending,
and defending) and social hierarchies (Ransom
et al. 2014, Baker et al. 2018). The most apparent pathology is the development of persistent,
non-debilitating granulomatous and purulent
inflammation at the site of injection; however,
this does not result in lameness, impaired mobility, or depression (Baker et al. 2018).
Although not previously reported for GonaCon-Equine, additional studies are warranted
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to evaluate the potential long-term side effects related to the presence of GnRH receptors
found in multiple organs throughout the body
(Kakar and Jennes 1995), including the pancreas
(Wang et al. 2001) and bladder (Coit et al. 2009).
The role GnRH plays throughout the body is
still being discovered, but it has been shown to
regulate cardiac contractile function (Dong et
al. 2011) and can affect the antler cycle in deer
vis à vis effects on testosterone (Durrant et al.
1996). However, most of the receptors identified in these tissues have very low binding affinity to GnRH, so effects of GonaCon vaccination on major organ function would likely be
negligible (T. Nett, Colorado State University,
personal communication).
Comprehensive reproductive studies were
conducted from 2009 to 2013 with individually identified free-roaming horses at Theodore Roosevelt National Park (TRNP), North
Dakota, USA. GonaCon-Equine vaccines were
administered by hand injection into gluteal
muscles, with the majority of mares pregnant
at the time of treatment. Foaling rates were 46%
in treated mares (13/28) compared to 73% for
control mares (19/26) for the second year (P =
0.04), and 55% (15/27) compared to 78% (21/27)
in treated and control mares, respectively, during the third year (P = 0.08). Despite that, contraceptive effectiveness was low to modest and
estimated to be only 37% (95% CI = 0.01–0.60)
and 28% (95% CI = -0.06–0.51) for the second
and third seasons, respectively (Baker et al.
2018). Similar results were reported for captive (Killian et al. 2008) and free-roaming (Gray
et al. 2010) horses in Nevada, suggesting that
while a single vaccination against GnRH may
be preferred from a practical perspective, multiple years of infertility may be experienced in
only a fraction of immunized animals.
More recent research, however, has demonstrated that GonaCon-Equine can provide more
effective and long-term contraception in freeranging ungulates when a single vaccination
is followed by reimmunization (Massei et al.
2015, Baker et al. 2018). Unlike results from the
single-dose trial, a booster administered 4 years
after the primary vaccination resulted in foaling rates of 0% (0/25), 16% (4/25), and 4% (1/24)
in treated mares (n = 25) compared to 84% for
control mares (n = 25), and these differences remained significant for 3 years (P < 0.001; Baker
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et al. 2018). During this 3-year period, average
vaccine effectiveness was estimated to be 92%
(95% CI = 0.81–1.00).
These results were not surprising because it
is well-documented that booster vaccinations
generally result in a more potent and enduring antibody production due to the anamnestic
(cell memory) response (Tizard 1982, Sallusto
et al. 2010). However, variation in the length
of time between primary and booster immunizations may lead to different levels and qualities of immune response (Dwivedi and Yadav
2012). Multiple studies have demonstrated that
when primary and booster immunizations are
applied too close together in time, memory cells
may not be able to mount an adequate immune
response, and the long-term effectiveness of the
booster can be diminished (Wistrom et al. 1999,
Castiglione et al. 2012, Ledgerwood et al. 2013).
These studies recommend that the number of
immunizations and intervals between vaccinations be carefully considered to optimize vaccine efficacy and reduce potential side effects.
From a practical standpoint, there is a need to
determine an optimal vaccination schedule for
free-roaming horses that balances the need for
minimizing animal handling while maximizing
vaccine effectiveness.
In a collaborative research effort, scientists at
Colorado State University, the BLM, NPS, and
the NWRC attempted to address this question in
a corollary experiment to Baker et al. (2018) at
TRNP during 2015–2020. The experimental design consisted of 4 booster intervals of decreasing length (i.e., 4, 2, 1, and 0.5 years) to test the
hypothesis that decreasing the interval between
primary and booster immunizations would
reduce the contraceptive efficacy of GonaConEquine in free-roaming horses. Although results
from this investigation are incomplete, preliminary results are promising. GonaCon-Equine
reimmunizations reduced (P ≤ 0.001) the probability of foaling between treated and control
mares for all treatment groups for all years of
the experiment (D. Baker, Colorado State University, unpublished data). Average effectiveness (defined as the proportional reduction in
annual foaling [number of mares with foals/total
number of mares in group] between treated and
control mares) was greatest for the 4-year treatment group and was estimated to average 88%
over a 6-year period, followed by 60% for the
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Table 1. Timing of primary and booster vaccinations with GonaCon-Equine, including sample size,
mode of vaccine delivery, contraceptive efficacy, and age at time of treatment for female free-roaming
horses (Equus ferus) at Theodore Roosevelt National Park, North Dakota, USA.
Booster
Sample Delivery Date of Date of Effective Mean age ± SE
Median age
interval (years) size
method primary booster years*
(years)
(range in years)
Primary Booster
2015–2020 5.4 ± 0.6 9.4 ± 0.7
2017–2020 3.0 ± 0.2 4.9 ± 0.2

Primary Booster
4 (2–17) 8 (6–21)
3 (2–4)

5 (4–6)

2018–2020 1.6 ± 0.3 2.6 ± 0.3
2018–2020 2.3 ± 0.8 3.3 ± 0.8

1 (1–5)

2 (2–6)

4

25

Hand

10/2009 9/2013

2

11

Dart

9/2013

9/2015

1

15

Dart

9/2015

9/2016

0.5

14

Dart

9/2015

3/2016

Control**

25

Hand

10/2009 10/2013 N/A

5.2 ± 0.6 9.2 ± 0.7

1 (1–14) 2 (2–15)
3 (2–11) 7 (6–15)

*Years of contraception significantly different (P <0.001) from controls.
**Control females were injected with saline solution.

2-year interval (over 4 years), and 64% and 62%
(over 3 years) for the 1- and 0.5-year intervals, respectively (Table 1). Reversibility was 24% (6/25),
45% (5/11), 50% (7/14), and 54% (7/13) for the 4-,
2-, 1- and 0.5-year booster interval treatment
groups, respectively (D. Baker, Colorado State
University, unpublished data). Collectively,
these preliminary data support the hypothesis
that increasing the interval between the primary and booster immunizations will increase the
level of effectiveness of GonaCon-Equine in freeroaming horses.
In summary, initial vaccination with GonaCon-Equine may provide only modest (≤2
years) suppression of reproduction, but when
followed by reimmunization from 6 months up
to 4 years, will result in a greater and longerlasting reduction in fertility in free-roaming
horses. Future research will further refine primary and booster vaccination intervals, test
remote delivery of vaccines, and evaluate potential long-term side effects of multi-year contraception using GonaCon-Equine.
Oocyte-specific growth factors. Mammalian reproductive success depends on an adequate
number of healthy oocytes being present within the ovaries. The total number of oocytes contained in the ovaries is established either before
or shortly after birth, depending on the species
(Eckery et al. 1996, Peters et al. 1976, Sawyer et
al. 2001, Tingen et al. 2009). Each primordial
follicle consists of an oocyte surrounded by a
few flattened somatic (i.e., granulosa) cells. Primordial follicle growth is initiated by means
that are not yet fully understood. This growth
is described by both an increase in oocyte size

and proliferation of granulosa cells due to interactions between these cell types. Initiation of
growth is a committed step, and the once quiescent follicles cannot return to a non-growing
state. Consequently, nearly all follicles become
atretic at some stage. It is estimated that <0.1%
of the oocytes populating the ovary are ever
ovulated; many follicles are lost during the process of selecting a dominant follicle for ovulation (Holesh et al. 2021). Entry of follicles into
the growth phase is tightly controlled to ensure
that an adequate number of follicles is available
throughout the reproductive life of the animal
(Reddy et al. 2010, Monniaux et al. 2014).
The physiological mechanisms controlling
initiation of follicular growth, follicular development, and thus the number of oocytes released
at ovulation involve a complex signaling cascade
among various organs, glands, and the ovaries
(endocrine) and a local exchange of molecules
directly between the oocyte and its surrounding somatic cells (paracrine) within the ovaries
(Peters et al. 1976, McNatty et al. 2007b, Binelli
and Murphy 2010). Communication between the
oocyte and granulosa cells is crucial for the survival and growth of the follicles (Matzuk et al.
2002, Gilchrist et al. 2004). Significant discoveries
have shown that the oocyte itself produces 2 key
regulatory growth factors, namely growth and
differentiation factor 9 (GDF9) and bone morphogenetic factor 15 (BMP15), that are essential
for regulating follicular growth and the ovulation rate (Dong et al. 1996, Galloway et al. 2000).
These discoveries also led to a paradigm shift in
recognizing that oocytes act as the control center of follicles and play a major role in their own
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growth and ovulation.
Both of these oocyte-specific growth factors
(OGFs: GDF9 and BMP15) have been shown to
be critical for early follicular growth in several
mammalian species (Shimasaki et al. 2004), including a marsupial (Trichosurus vulpecula; Eckery et al. 2002), sheep (Ovis aries; Juengel et al.
2002), and humans (Juengel and McNatty 2005).
These OGFs cooperate in a species-specific way
to regulate maturation of the oocyte and communicate with the granulosa cells (Lin et al.
2012). Ewes that have double copy mutations
in the genes encoding either GDF9 or BMP15
are sterile, but otherwise healthy. In these animals, follicles do not progress beyond the primary stage of growth. Interestingly, in animals
with only a single copy mutation in either of
these genes, and thus presumably producing
only half the amount of protein, ovulation rate
is increased (Galloway et al. 2000, McNatty et
al. 2005). In laboratory mice, GDF9 knockout females (i.e., females in which genes responsible
for GDF9 have been made inoperative) are sterile, but BMP15 knockouts only demonstrate decreased litter size (Moore and Shimasaki 2005).
Mutations in GDF9 or BMP15 have also been
found in women, and are believed to be a cause
of premature ovarian failure (Di Pasquale et al.
2004, Pouresmaeili and Fazeli 2014).
McNatty et al. (2007a) demonstrated that ewes
could be sterilized by immunization against either GDF9 or BMP15. Moreover, specific regions
of each growth factor were identified that were
important for the biological activity of the respective proteins. This enabled the production
of effective peptide vaccines that were specific
to those regions. The homologous regions were
identified in cows and sheep and found to have
100% amino acid sequence identity. In cows,
vaccination against these peptide regions resulted in suppressed reproductive cycles in some
animals, while others experienced an increase
in ovulation rate (Juengel et al. 2009). In whitetailed deer, BMP15 vaccinated animals became
more fecund (Eckery et al. 2014). This may have
been due to the biological activity of BMP15 being only partially blocked (similar to the effect
of a single copy mutation in sheep) and causing
an increase in ovulation rate. Deer vaccinated
against GDF9 were also more fecund during the
first year but were infertile in years 2 and 3. The
effects observed during the first year could have
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been because of the timing of vaccination in relation to onset of breeding (i.e., does may not have
had an opportunity to mount a sufficient immune response prior to breeding). Regardless, it
appears that GDF9 was only partially inhibited
during the first breeding season. Results from
all of these studies demonstrate that vaccination
against GDF9 and BMP15 has the potential to
control fertility in a range of species.
Genes for both GDF9 and BMP15 have been
identified in the mare (Wade et al. 2009) and
shown to be expressed in equine oocytes (Campos-Chillon et al. 2015). Therefore, it is likely
that these growth factors have similar functions
in horses. We recently tested the hypothesis that
vaccination against either GDF9 or BMP15 would
alter reproductive function in the mare. Domestic mares (n = 10) received an initial dose and 3
boosters administered in neck muscles at 6-week
intervals beginning in February 2016. The vaccines used keyhole limpet hemocyanin as a carrier protein and Seppic Montanide™ Pet Gel A as
a mild adjuvant. While BMP15-immunized mares
experienced a 50% decrease in ovulations, those
vaccinated against GDF9 did not differ from controls, yet both groups demonstrated altered estrous activity and a significant decrease in follicle
size prior to ovulation (Davis et al. 2018).
With this information, a study was initiated
for an additional 2-year experiment in which
free-roaming mares in a holding facility (n =
10) were immunized against both GDF9 and
BMP15 simultaneously. The vaccine was administered in the first year only, as described
above. Preliminary results are encouraging, as a
marked decrease in ovulations (>88%) has been
observed over the 2-year period (D. Eckery and
J. Bruemmer, NWRC, unpublished data). Additional studies focused on identifying an ideal
adjuvant, length of efficacy of a single injection,
and safety in pregnant mares are either ongoing or planned for the near future.
Other considerations for immunocontraception. In
addition to vaccine design considerations like antigen target, adjuvant and formulation, delivery
method, and vaccination sites and schedules, a
variety of intrinsic factors can affect an animal’s
ability to mount an immune response. Abolins et
al. (2011) demonstrated that wild mice have more
variable immune responses than do laboratory
strains. Environmental variables may affect an
animal’s health and nutritional status, reducing
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Figure 5. Some commonly used intrauterine devices (IUDs) in mares
(Equus ferus) include (A) magnetic iUPOD®, (B) silastic O-ring, (C) silastic
Y-design, and (D) T-shaped copper IUDs (photos courtesy of C. Gradil [A]
and G. Holyoak [B, C, and D]).

its ability to mount an effective immune response
after vaccination (Gross and Newberne 1980,
Ponton et al. 2011), and closed versus open populations will affect field trial results (Dawson and
Hone 2012). The range of variables that may affect response to vaccination can make it challenging to draw firm conclusions from initial trials. In
the future, new antigen targets may be identified,
and different research tools can be used to evaluate vaccine efficacy. For example, IgG4/7 detection may more precisely gauge immune response
(Bechert et al. 2018), and anti-Müllerian hormone
may further characterize reproductive effects of
vaccination (Jooné et al. 2018).

Intrauterine devices
One method of contraception receiving renewed interest is the IUD (Holyoak et al. 2021,
Joonè et al. 2021). Insertion of an IUD into the
uterus of a free-roaming horse unaccustomed to
handling may require mild sedation. Use of an

IUD in pregnant mares would not be advised
because cervical manipulation may result in a
high incidence of abortion while also expelling
the IUD. While the actual mechanism of action
for contraception resulting from the placement
of IUDs is uncertain, multiple theories exist, such
as mechanical interference with sperm transport,
copper IUDs possessing sperm cytotoxic properties, IUD interference with embryonic migration
through the uterus in the early days of pregnancy (Ortiz et al. 1996), or chronic inflammation
surrounding the IUD, which interferes with embryonic development (Killian et al. 2008, Joonè et
al. 2021). Some veterinary practitioners also use
IUDs in an attempt to modify estrus behavior in
mares; however, reports of success in prevention
of estrus behavior are anecdotal. Successful IUD
placement (i.e., high retention and decreased
pregnancy rates) appears to be affected by size,
shape, weight, and material composition of the
IUD (Figure 5).
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Retention and contraception. All results for various IUDs presented below are from captive or
pasture trials with domestic horses.
Daels and Hughes (1995) performed a
10-month trial using silastic O-ring IUDs; all
treated mares (n = 6) retained the IUD for the
study duration and failed to become pregnant
in the presence of a fertile stallion. However,
the silastic O-ring did not provide the same
rate of success for Baldrighi et al. (2017), where
differing sizes and durometers (hardness) of
the silastic O-rings resulted in a loss rate of
60% in 24 mares housed with 2 breeding stallions. Mares pasture bred within a week after
IUD insertion were at highest risk for losing
their IUD (Baldrighi et al. 2017). Holyoak et al.
(2021) redesigned the silastic O-ring IUD and
performed a 20-month pasture breeding study
with a silastic Y-design, “fundus-seeking” IUD
(n = 20). The Y-design IUD had a 75% retention
rate and prevented all pregnancies when IUDs
were retained, after pairing insertion with a single injection of bio-release progesterone, which
prevented breeding behavior in the days immediately following insertion.
Copper IUDs, used for contraception in women, have been tested in mares with some success.
When compared with a copper linear shaped
IUD, and a silastic-coated copper ring IUD, the
380 Copper T IUDs were the most promising.
Copper T IUDs were placed in 7 pony mares and
were effective for 3 years (n = 1), 4 years (n = 2) and
5 years (n = 1; Killian et al. 2008).
Nie et al. (2003) placed glass ball IUDs into the
uteri of 24 mares. Within 11 days, 6 of 12 mares
with a 25-mm glass ball expelled their IUD;
however, all 12 mares given 35-mm glass balls
retained theirs for at least 4 estrous cycles. The
retention rate of IUDs in the presence of breeding activity was not tested. Argo and Turnbull
(2010) inserted 35-mm borosilicate glass balls
into the uteri of 4 Welsh pony mares, and they
all retained the IUD until manual removal after
2–5 estrous cycles. Even though the larger glass
balls had higher retention rates, Rivera del Alamo et al. (2008) and Klein et al. (2016) lost only
1 IUD when using 20-mm water-filled plastic
balls over 4 months (n = 30 for the 2 studies).
Magnetic IUDs (comprised of 3 separate,
shatter-proof, 26-mm oblong-shaped arms)
were retained in the uteri of 29 mares for 2–9
months until manual removal (Gradil et al.
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2019). Joonè et al. (2021) inserted magnetic
IUDs into the uteri of 7 mares following artificial insemination; mares failed to become
pregnant and retained the IUD over 3 months.
Retention of the magnetic IUDs in the presence
of breeding behavior with a stallion has yet to
be reported.
Uterine health. Some risks and potential negative long-lasting impacts of IUDs have been described, such as endometritis or pathology, as
well as severe complications induced from glass
balls shattering (Klabnik-Bradford et al. 2013,
Turner et al. 2015, Vanderwall 2015). Although
IUDs cause chronic inflammation, they generally
do not induce irreversible pathologies (Daels and
Hughes 1995, Nie et al. 2003, Gradil et al. 2019,
Holyoak et al. 2021, Joonè et al. 2021). Daels and
Hughes (1995) reported that all 6 mares treated
with a silastic O-ring IUD experienced a worsening of endometrial biopsy score as a result of
inflammation; however, neutrophilic uterine cytologies (i.e., bacterial infections) resolved within
1 week following IUD removal, and all mares
subsequently became pregnant. In contrast, Rivera del Alamo et al. (2008) reported that only 3 of 9
mares had a neutrophilic uterine cytology. The Ydesign IUD, made of the same silastic material as
O-ring IUDs, also differed in that 11 of 20 mares
had either no change or showed an improvement
in endometrial biopsy score; 12 of the 20 mares
became pregnant after IUD removal (Holyoak et
al. 2021). Nie et al. (2003) reported that of 24 treated mares, only 1 mare experienced a decline in
endometrial biopsy score, and 17 of 23 mares conceived following glass ball removal. In the Gradil
et al. (2019) study, all 8 mares became pregnant
via artificial insemination in the breeding season
following IUD removal. Uterine fluid in the presence of an IUD does not appear to impact future
pregnancy rates once the IUD is removed (Nie et
al. 2003, Holyoak et al. 2021). Endometrial biopsy
score differences could be due to varying durations of project length, differences in IUD material, or subjective interpretation by those scoring
the biopsies.
Ovarian cyclicity and estrus behavior. Multiple
publications describe uninterrupted ovarian
cyclicity in the presence of an IUD (Daels and
Hughes 1995, Argo and Turnbull 2010, Holyoak
et al. 2021). Reported mean inter-ovulatory intervals were 19 ± 1.4 days (Daels and Hughes
1995) and 24 ± 0.57 days (Argo and Turnbull
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Table 2. Comparison of administration requirements and animal welfare impacts of different
fertility control and sterilization options for free-roaming horses (Equus ferus). Modeled after
Hampton et al. (2015).
Administration*
Treatment

Capture

Surgery Multiple Frequency of
doses
treatment**

Animal
welfare
impact***

Immunocontraception
ZonaStat-H (primer + booster at 4 weeks)

-

-

+

1 year

+

PZP-22

±

-

+

2 years

+

SpayVac

±

-

-

4 years

+

GonaCon-Equine****

±

-

+

2 years

+

BMP15-GDF9

±

-

?

?

+

+

-

-

?

++

Bilateral ovariectomy

+

+

-

Permanent

+++

Castration

+

+

-

Permanent

+++

Intrauterine devices
Sterilization

*Administration: - not required; ± may be required; + required; ? unknown
**Frequency of treatment: based on best results from a single treatment representing a significant
difference from controls in published studies (note: ZonaStat-H requires boosters as part of the
single treatment)
***Impact of treatment: + minimal animal welfare impact; ++ mild animal welfare impact (some
restraint; procedure is minimally invasive); +++ highest animal welfare impact (restraint and
sedation required; procedure is invasive)
****GonaCon-Equine boosters given 4 years after the primary vaccination provide 6 years of
contraceptive efficacy (see Table 1; D. Baker, Colorado State University, unpublished data).

2010), compared to 21 ± 2.4 days for controls
(Ginther and Pierson 1989). Similarly, Holyoak et al. (2021) reported continued evidence
of ovulation in mares possessing the silastic
Y-design IUD. On the other hand, Nie et al.
(2001) reported extended luteal function in 42%
of mares treated with glass balls; a follow-up
study revealed a 29% rate of extended luteal
function (7 of 24) in treated mares compared to
13% for control mares (Nie et al. 2003). Gradil et
al. (2019) reported that all mares (n = 14) experienced a prolonged diestrus (51 ± 22 days) when
magnetic IUDs were inserted at any stage of the
estrous cycle, and this increased to 73 ± 36 days
when the IUD was inserted during estrus.
Mares with an IUD have failed to demonstrate
any change in social or sexual behavior (Argo
and Turnbull 2010). Mares teased to a stallion
demonstrated behavior consistent with the concentration of circulating progesterone, rather
than presence of the IUD (Nie et al. 2003). Gradil
et al. (2019) are the only researchers to report
that mares with magnetic IUDs exhibited “subdued estrus-related behaviors” with “improved

rideability” as related to a “general demeanor
shift.” These findings are subjective, and blinded
studies are necessary for confirmation.
Despite hypotheses of prostaglandin secretion
being affected by the presence of IUDs (i.e., interference with maternal recognition of pregnancy),
how IUDs may prolong the life span of corpora
lutea has yet to be elucidated (Rivera del Alamo et
al. 2008, Klein et al. 2016, Rivera del Alamo et al.
2018). Larger scale, long-term contraceptive studies in free-roaming horses are currently underway
to assess how long IUDs can be maintained in the
uteri of mares being bred by a harem stallion.

Surgical options
The BLM has been supporting research to explore 3 methods of surgical sterilization in freeranging mares (BLM 2016): tubal ligation (McCue et al. 2000), hysteroscopically guided laser
ablation of oviduct papilla (Edwards et al. 2021),
and ovariectomy via colpotomy (Collins and
Kasbohm 2017). Various methods of vasectomizing and castrating stallions have also been explored (Scully et al. 2015). Surgical options result

Figure 6.
Free-roaming
horse fertility control options • Bechert et al.
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A

One hand secures the ovary in the
abdominal cavity and places the chain
écraseur around the pedicle, while the other
hand steadies the écraseur. An assistant
tightens the écraseur.

B

One hand secures the ovary in the
abdominal cavity and places the chain
écraseur around the pedicle, while the
other hand tightens the écraseur.

Figure 6. Different physical environments and available resources for ovariectomies conducted on mares
(Equus ferus) in (A) an indoor surgical suite, and (B) a horse stall in the field. Note several veterinarians in
(A) are fully gowned and gloved for surgery, the room is climate-controlled, and the hospital provides access
to a complete suite of medical drugs, supplies, and equipment. Ovariectomies conducted in the field are less
able to control environmental variables (e.g., wind, temperature) and, depending on location, have comparatively fewer medical resources to draw upon (photos courtesy of T. Prado [A] and U. Bechert [B]).

in permanent sterility; however, these methods
are comparatively more invasive, time consuming, and expensive over the short-term than previously described fertility control options (Table 2).
Additionally, procedures associated with few
complications when performed with domestic
horses are likely to have higher complication
rates when performed with free-roaming horses

because horse demeanor is different, and the
same precautions, sterile environments, and access to medical resources are difficult to duplicate
in the field (Figure 6).
Ovariectomy. Spaying (i.e., ovariohysterectomy) is widely practiced in companion animals
and involves removal of the ovaries, oviducts,
and uterus. Domestic horses are not usually
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spayed; instead, ovariectomies (i.e., removal
of the ovaries) are sometimes performed to remove tumors, create a teaser mare, produce a
recipient mare for embryo transfer, or diminish
behavioral signs of estrus (Hooper et al. 1993).
However, bilateral ovariectomy commonly results in continued display of sexual receptiveness, with loss of normal cyclic activity, so it is
unlikely to resolve unwanted sexual behavior
(Hedberg et al. 2007). This is because progesterone is the hormone responsible for inhibiting
behavioral signs of estrus (Watson and Hinrichs
1989), and progesterone is produced by corpora
lutea, which form after ovulation and would
not be present in the absence of the ovaries.
Progesterone is also necessary to maintain
pregnancy in mammals, but ovaries become less
necessary for the maintenance of pregnancy in
horses between days 50 and 70 of gestation. In 1
study, all mares aborted when ovariectomized
prior to 45 days of gestation, about half of the
mares carried their foal to term when they were
ovariectomized at 50 to 70 days of gestation,
and all mares carried their pregnancy to term
when ovariectomized after 140 days of gestation (Holtan et al. 1979). However, the stage of
gestation will affect the difficulty of performing
an ovariectomy, with advanced pregnancy increasing the risk of complications.
There are different surgical approaches for
removing the ovaries of a mare (Hooper et
al. 1993, Pader et al. 2011); however, bilateral
ovariectomy performed through a colpotomy
(incision via the vagina) is comparatively quick
and less expensive than other approaches,
which require general anesthesia. A colpotomy
is performed with the mare standing; it can be
completed in 15–20 minutes by an experienced
veterinarian; a surgical facility is not required;
and the only specialized instrument required is
a chain écraseur (Prado and Schumacher 2019).
Briefly, after surgical preparation, an incision
1–3 cm long is made in the anterior-dorsallateral aspect of the vagina, which is enlarged
by blunt dissection to allow the surgeon’s hand
to enter the abdomen (Figures 2B and 6). The
ovary is identified and isolated by direct palpation, and a local anesthetic agent is injected
into the ovarian pedicle, which contains the
ovarian artery and vein. An écraseur is placed
around the pedicle and tightened using a rachet
until the pedicle is severed. The ovary is then
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removed manually, and the same procedure is
performed on the remaining ovary (Prado and
Schumacher 2019).
The vaginal incision is generally left unsutured to heal by second intention because suturing is difficult and may induce vaginitis,
causing the mare to strain. Within about 3 days,
the incision contracts to a diameter that accommodates only 1 finger, and the hole is usually sealed from the abdomen within 3 weeks
(Prado and Schumacher 2019). Because the
vaginal incision is left unsutured, ovariectomy
through a colpotomy should not be performed
on mares that suffer from vesicovaginal reflux
(i.e., pooled urine). Mares having poor perineal
conformation should receive a Caslick’s vulvoplasty, or perhaps even a vestibuloplasty, to
prevent pneumovagina and subsequent contamination of the vestibule, vagina, and abdomen, which can result in septic peritonitis (Prado and Schumacher 2019).
Complications of bilateral ovariectomy performed through a colpotomy are rare when a
domestic mare is correctly prepared for surgery
and precautions are taken during and after the
procedure (Prado and Schumacher 2019). Prior
to surgery, colonic fecal balls should be eliminated because they can be mistaken for ovaries,
food should be withheld for 24 hours, a laxative (e.g., mineral oil) should be given by nasogastric intubation, and the mare’s hematocrit
and serum total protein levels should be determined. Sedatives should be given just prior to
and during the surgery as needed, and later,
antimicrobials and anti-inflammatory drugs
should be administered. Movement of mares
after surgery should be limited, and individuals should be held and observed for 5–7 days to
detect any post-surgical problems.
Complications after a bilateral ovariectomy
via colpotomy can include infections and peritonitis, hernias, vaginal adhesions, post-operative
pain, but most importantly hemorrhage and
evisceration (Embertson 2009). The most serious
potential complication of performing ovariectomies through a colpotomy is fatal hemorrhage
because, with this approach, hemostasis of the
ovarian arteries and veins relies on crushing
them with an écraseur, and intra-abdominal
hemorrhage is difficult to detect because the
procedure is performed blindly. Inadvertent
perforation of the vaginal branch of the uter-
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ine artery would cause fatal hemorrhage, with
death occurring within minutes; however, perforation can be avoided if the artery is first identified by palpation and by incising the fornix of
the vagina at the 10:30 or 1:30 o’clock position
(Embertson 2009, Prado and Schumacher 2019).
Clinical signs associated with substantial blood
loss (e.g., fast heart and respiratory rates, weak
pulse, pale mucous membranes, prolonged capillary refill) may be difficult to observe if the
mare cannot be safely handled (Mudge 2014). If
possible, the mare’s hematocrit and serum total
protein levels should be determined periodically
after surgery; however, a decrease in total serum
protein is often not evident for at least 6 hours,
and a decrease in hematocrit may not be evident
for 12–24 hours, making hemorrhaging difficult
to identify (Getman 2009).
To decrease the likelihood of evisceration,
some surgeons recommend leaving the mare
tied for 4–5 days after colpotomy to prevent recumbency (Nickels 1988). However, in 1 study,
none of 51 mares that were bilaterally ovariectomized via colpotomy eviscerated, even though
they were left untied in stalls for 7 days (Colbern
and Reagan 1987). Generally, ovariectomized
mares can be allowed unrestricted exercise after about 5 days (Colbern 1993, Moll and Slone
1998, Embertson 2009, Pader et al. 2011).
Bilateral ovariectomy was used as a means
to control fertility of free-roaming horses at the
Sheldon National Wildlife Refuge in northern
Nevada. Mares (n = 114) were ovariectomized
by colpotomy, held for 3–8 days after surgery,
and then returned to the range along with 36
untreated mares (Collins and Kasbohm 2017).
Losses due to complications with ovariectomies
were not reported; however, 2% of ovariectomized mares and vasectomized stallions (n = 8
of 385 total) were lost pre-release (Collins and
Kasbohm 2017). Post-surgical observations were
made aerially, and the recapture rate a year later
was 85.3% for the 150 released mares; survival
rates for treated mares (85.1%) did not differ significantly from untreated mares (86.1%).
Protests from horse advocacy groups have
halted additional ovariectomy field studies, and
a report by the NRC (2013) states, “The possibility that ovariectomy may be followed by prolonged bleeding or peritoneal infection makes
it inadvisable for field application” (130). Veterinary surgeons agree with this because of the se-
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rious complications that can accompany the procedure and the challenge of addressing these in
the field (J. Schumacher, P. Mulon, and P. Jones,
University of Tennessee, personal communication). Future research could explore safer, alternative forms of permanent sterilization for freeroaming mares, with consideration given to the
unique challenges encountered in the field.
Castration. Castration is familiar to most people as a tool to control fertility and behavior in
males. In pets and livestock, castration is used
to curb undesirable reproductive behaviors and
aggression (McGreevy et al. 2018). In the United States, the majority of male pet dogs (Canis
familiaris) and cats (Felis catus) are castrated
(Houlihan 2017), and castration is among the
most common surgeries performed on stallions
(Schumacher 1996; Figure 7). Despite this, there
is surprisingly little longitudinal research on
the effects of castration, although the literature
is increasing for dogs (e.g., Hart et al. 2020).
Castration affects male behaviors by removing production of androgens in the testicles,
with concentrations of testosterone decreasing
rapidly (within 6 hours) after surgery in the
horse (Thompson et al. 1980). Removal of the
testicles and their production of hormones also
affects other endocrine glands (Taravat et al.
2017), thus compounding effects on behavior.
The literature on a wide range of species shows
mixed effects of castration on behavior, partly
because behavior can be influenced by so many
factors. Castration has been found to reduce aggression in rodents (Barfield et al. 1972, Christie
and Barfield 1979, Hume and Wynne-Edwards
2005, Lofgren et al. 2012, Gale et al. 2019), Japanese macaques (Macaca fuscata; Takeshita et al.
2017), and domestic dogs (Maarschalkerweerd
et al. 1997), although no changes were reported
after castration in free-ranging dogs (Garde et
al. 2016), prairie voles (Microtus ochrogaster; Demas et al. 1999), and other non-human primates
(Wilson and Vessey 1968, Epple 1978). In horses, effects of castration on aggression have rarely been examined, with some authors reporting
that castration controlled aggressive behavior
(Smith 1974), while others report that aggression can continue to be problematic (Line et al.
1985, i Rios and Houpt 1995, Schumacher 2006).
To put this in context, 1 study found a similar
frequency of aggression in a group of geldings
as a group of mares (Vervaecke et al. 2007).
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Figure 7. Recovering free-roaming geldings (Equus
ferus) a few hours after castration at the Bureau
of Land Management Delta Wild Horse and Burro
Corral, Utah, USA. Shaved patches are related to
freeze-marking for individual identification and not
related to surgery (photo courtesy of S. King).

Although castration is most commonly
thought to extinguish reproductive behaviors,
in the few studies that have explored this, most
have found that expression of sexual behavior remained but may diminish over time—for
example, in non-human primates (Wilson and
Vessey 1968, Phoenix 1974, Zumpe et al. 1992),
goats (Capra aegagarus hircus; Hart and Jones
1975), and free-ranging dogs (Garde et al. 2016).
In domestic horses, persistence of reproductive
behavior following castration was reported as
problematic by 69% of respondents to a survey (i
Rios and Houpt 1995) and was shown in 20–30%
of geldings whether castrated pre- or post-pubertally (Smith 1974, Schumacher 2006). Reproductive behavior shown by domestic geldings
included herding, penile erection, mounting,
and copulation (Pearce 1980, Cox 1986, i Rios and
Houpt 1995, Schumacher 2006). These behaviors
were not associated with prior sexual experience
(Cox 1986); in some horses, these behaviors were
exhibited from the time of castration, with others
showing it only later in life (i Rios and Houpt
1995). Exhibition of sexual behaviors may be
situational in geldings: 1 author reported that it
was shown by geldings only when moved to a
new environment (Pearce 1980), indicating that
these behaviors could be less dependent on hormones than on cerebral or social mechanisms
(Smith 1974, Fritz et al. 2019).
For free-roaming horses, castration as a male
fertility control method that has no impact
on their aggressive or reproductive behavior
sounds promising, as this implies that it could
reduce foaling rates but will have little im-
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pact on their social structure. However, until
a recent study (King et al. 2022), there was no
research on how geldings behave in a reproductive herd. In King et al.’s study (2022), behavioral data were collected on free-roaming
stallions both before and after castration and
in comparison to intact males at Conger HMA
in western Utah. There was no effect of castration on expression of agonistic behaviors. Reproductive behaviors continued to be shown
by geldings throughout the study, with little
difference between them and intact males. Although some geldings continued to associate
with mares, the number of mares in a gelding’s
harem decreased over the course of the study in
comparison to intact controls (King et al. 2022).
Research on Icelandic ponies in a large pasture,
where mares, foals, and juveniles were kept
with geldings but no intact stallions, found that
while mares displayed threat behavior to geldings more often than to other mares, there was
no effect of geldings on the welfare of mares or
foals (Van Dierendonck et al. 2004, Jørgensen et
al. 2009). In a population in Japan where geldings were in a reproductive herd (Kaseda 1981,
Kaseda et al. 1997), and in the studies in Iceland where geldings were with mares and foals
(Sigurjónsdóttir et al. 2003, Van Dierendonck
et al. 2004), geldings tended to group together;
however, this was not seen at Conger HMA
(King et al. 2022). Testosterone levels in intact
males vary by season, and harem stallions have
higher levels of testosterone than bachelors
(Berndtson et al. 1974, Angle et al. 1979, Turner
and Kirkpatrick 1982, McDonnell and Murray
1995, Sterregaard et al. 2002). As geldings have
no production of testosterone, this would be expected to affect their dominance rank, yet geldings were found to be dominant over mares in
some studies (Montgomery 1957, Tyler 1972,
Houpt and Keiper 1982), although the social
structure in Icelandic ponies was dominated by
mares (Sigurjónsdóttir et al. 2003).
Success of a fertility control method is ultimately assessed by its effect on foaling rate. Preliminary data indicate that castrating stallions
in a free-roaming herd reduces foaling rate over
the short-term, but the impact is reduced over
subsequent years as intact males, which were
young at the time of castration, mature (King et
al. 2022). Two other studies where male fertility was controlled in a free-roaming horse herd,
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by microencapsulated testosterone propionate (Kirkpatrick et al. 1982, Turner and Kirkpatrick 1982) or vasectomy (Eagle et al. 1993),
found similar results: during the first breeding
season after treatment, there were fewer foals
in groups where the harem stallion had been
treated. Foals born in these harems were due
to pregnant mares changing groups (Eagle et
al. 1993). Mares exhibit mate choice (Pickerel et
al. 1993), meaning that they select the stallions
with which to copulate. In populations with
few group changes, most foals are sired by the
harem stallion (Bowling and Touchberry 1990,
Feh 1990, Kaseda and Khalil 1996, Gray et al.
2011). Thus, in stable populations, male fertility
control will likely show some success at reducing foaling rate initially. However, in unstable
populations with high rates of mares changing groups (i.e., low mare fidelity to a stallion),
there would be reduced efficacy of male fertility
control unless most males are castrated (Nelson
1980, Miller 1981). Stability of horse groups can
be affected by gathers (Gray et al. 2011, Nuñez
et al. 2015). As current free-roaming horse management relies on gathers and removals in addition to fertility treatments, castrating stallions
as a form of population growth control cannot
depend on group stability for success and is
likely to have a substantial and longer-term
effect on foaling rates only when the majority
of males (>80%) in a population are castrated
(Garrott and Siniff 1992).

Considerations for implementation
Operational hurdles, including regulatory,
financial, and logistical issues, must be negotiated before fertility control measures for freeroaming horse populations can be effectively
implemented. Such constraints can be placed
into 5 categories: (1) comprehensive plan development, (2) regulatory requirements, (3) animal
welfare, (4) environmental conditions, and (5)
logistics and key personnel.
Comprehensive plan development. A comprehensive plan for managing free-roaming horses is
essential for defining a course of action, securing
funding, and demonstrating buy-in from stakeholders. Although there is no regulatory requirement for a comprehensive plan, the cost and
complexity involved in management actions
makes this necessary. In addition to Resource
Management Plans (RMPs) and National Envi-
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ronmental Policy Act (NEPA) documents, a comprehensive plan develops and justifies budgets
and helps build consensus among stakeholders.
In addition to FREES, a consortium of conservation, animal welfare, and agricultural groups
all support the use of contraception to keep
free-roaming horse populations within AML
(American Society for the Prevention of Cruelty to Animals [ASPCA] et al. 2020); however,
some animal rights advocates, such as Friends
of Animals, oppose any intervention into the autonomy of free-roaming animals, including the
use of contraceptives. A well thought out management plan and supporting implementation
documents are more likely to survive inevitable
court challenges, which can seriously disrupt
operations by diverting resources and interfering with plan implementation.
Regulatory requirements. Part of the planning
process includes complying with NEPA requirements, which come into play if federal funds or
approvals are required in an action that could
significantly affect the environment. Actions
taken by the BLM, USFS, tribal agencies, and the
NPS all fit into this category; however, actions
taken by states, tribes, and private landowners
are exempt from NEPA, if federal funds and
approvals are not involved. The BLM develops
RMPs for multiple planning unit areas, and
plans are revised every 10–20 years. For each
RMP, NEPA requires a comprehensive Environmental Impact Statement (EIS) “if a proposed
major federal action is determined to significantly affect the quality of the human environment”
(EPA 2020). This process is not intended to guarantee that no adverse environmental impact will
occur, only that potential impacts are identified
and given due consideration (and impacts may
be positive). An Environmental Assessment (EA)
considers the potential effects of proposed actions within the scope of an existing EIS. These
documents also consider the consequences of
alternatives, such as other forms of fertility control, as well as taking no action.
With respect to managing free-roaming horse
populations, all types of potential actions must
be considered in the RMP. These would include
removals as well as the use of 1 or more fertility
control options. An amendment to the RMP is
required if an action that was not contemplated
initially is now being considered or if significant new scientific information about potential
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effects has become available. Major plan revisions or new plans trigger the need for a new
EIS, while an amendment could require preparation of either an EA or EIS, depending on
the scope of the change. Court challenges are
inevitable and can be costly because they may
derail the planning and preparations that have
taken place. The best way to ensure that actions
planned by federal management agencies can
survive court challenges is to employ seasoned
personnel who are skilled in preparing defensible NEPA documents; the BLM often contracts
with vendors to achieve this (BLM 2020).
Contraceptive agents must be registered with
the appropriate government agency unless they
are used under an Experimental Use Permit or
similar approval. For fertility control agents like
immunocontraceptive vaccines, the appropriate
legislation is the Federal Insecticide, Fungicide,
and Rodenticide Act (FIFRA), and EPA is the responsible agency. However, because of the data
requirements and costs associated with registering such products, many organizations have
stopped pursuing registration if product sales
would be limited (Fagerstone et al. 1990). The
costs of registration under FIFRA, which can total several hundred thousand U.S. dollars, have
to have a reasonable prospect of being recovered
through sales. However, many companies may be
reluctant to invest substantial amounts of money
where the apparent returns appear quite limited.
Animal welfare. The well-being of horses as
well as staff is paramount during capture,
handling, and treatment. One aim is to bring
free-roaming horse populations into balance
with their environment to ensure that they
do not have to face starvation or dehydration,
which is 1 of the 5 freedoms of animal welfare
(ASPCA 2021). Gathers are governed by a comprehensive animal welfare policy (BLM et al.
2015), which ensures that contractors follow
animal welfare protocols (e.g., use of handling
aids such as signaling flags, hand signals, and
voice commands). Helicopters are used so that
animals are encouraged to move in the desired
direction but are not panicked. Visual barriers
(e.g., burlap or plywood) on corrals and drift
wings must meet standards that minimize
stress to the animals. For example, when foals
become separated from their dams, efforts must
be made to reunite them. A veterinarian must
be present at each gather to ensure that any ani-
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mal in distress is properly attended. Should the
veterinarian believe that an animal needs to be
removed to receive off-range attention or be euthanized, the recommendation is made to the
BLM officer in charge who makes the final decision (BLM, unpublished memorandum). Animals to be taken off-range must be separated
and transported, according to sex and age, and
with specified minimum space requirements.
A functional management plan for free-roaming horses must address both short- and longterm aspects, and employing 1 or more fertility
control tools in concert with needed removals
may offer the best opportunity for success (NRC
2013, Garrott 2018). For many populations, it is
necessary to capture and remove excess animals
from the range to bring the herd size down to
AML quickly. Gathers also provide opportunities to administer contraceptive agents, which
should be done when ambient temperatures are
not extreme. Historically, BLM has performed
removals at an HMA approximately every 4
years, with exceptions for emergency circumstances resulting from range fires, extreme
drought, and animals that pose public safety
hazards along highways. Capture methods for
free-roaming horses used by BLM usually have
good animal welfare outcomes in comparison to
wildlife capture operations (Scasta 2020).
Environmental conditions. The productivity of
field operations is influenced by weather, forage
and water availability, and accessibility within
an HMA. The ability to work in an HMA during
some seasons can be restricted by environmental conditions, including mud, terrain ruggedness, elevation change, tree cover, and extreme
temperatures (Turner 2015). Snow and rain can
significantly interfere with access to some areas
during particular seasons. The HMAs encompass a wide range of climatic, edaphic, and vegetation conditions (Figure 1), which can affect
horse herd growth rates, abundance, and animal
body condition. Thus, these influence management options, such as the prioritization of areas
in greatest need of action.
Logistics. For gathers at large and remote
HMAs, the BLM relies on contractors with portable corral systems, temporary fencing, transport
trucks, helicopters, field holding facilities, and
other essential items (e.g., water troughs, high
quality hay) that are needed to capture, handle,
and accommodate animals to be removed from
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can Society for the Prevention of Cruelty to Anithe range. Additionally, the BLM has worked
mals, New York, New York, USA, <https://www.
with local volunteers to dart free-roaming horsaspca.org/sites/default/files/upload/images/
es with contraceptives, but this is possible only
aspca_asv_five_freedoms_final1.ashx_.pdf>.
when the population is small and approachable,
Accessed February 15, 2021.
individual horses are known, and volunteers are American Society for the Prevention of Cruelty to
willing and able to be trained.
Animals (ASPCA), American Farm Bureau Fed-

Management implications

Cooperation among multiple stakeholders is
needed to orchestrate permit requirements, accurately characterize HMAs, adjust AMLs, select
1 or more fertility control options to implement
in conjunction with removals for herd management, and monitor a myriad of factors to continually refine population management strategies. However, additional consideration should
be given to how population control methods,
even when deemed successful, may affect longterm management outcomes. For example, successful management of the closed population of
Assateague Island horses resulted in increased
longevity of individual mares—an unforeseen
consequence of fertility control. Methods used to
determine AMLs in order to maintain “a thriving natural ecological balance” have been questioned, especially when policy decisions determine forage allocations among multiple users.
The sociopolitical framework within which the
BLM and other organizations must operate adds
additional layers of complexity to effective management of free-roaming horses, and educating
politicians and the general public may facilitate
implementation of science-based management
strategies.
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